Winters Chad 4

What Happened
Chad Winters, Vice President and Chief Accounting Officer of West Pharmaceutical Services (WST), was granted two awards of restricted stock units (RSUs) on 2026-03-01: 340 RSUs and 808 RSUs, for a total of 1,148 RSUs. The transaction is reported as derivative awards with an acquisition price of $0.00 (typical for RSU grants); no cash was exchanged and no immediate shares were issued.

Key Details

• Transaction date: 2026-03-01; Form 4 filed: 2026-03-03 (appears timely).
• Awards: 340 RSUs and 808 RSUs (total 1,148 RSUs); price shown as $0.00.
• Vesting: The RSUs vest in four equal annual installments beginning March 1, 2027 (per filing footnote).
• Shares owned after transaction: not specified in the provided filing details.
• Footnotes: F1 clarifies each RSU equals a contingent right to one share; F2 gives the four-year vesting schedule; F3 notes a standard four-year option vesting schedule but no stock option transaction is reported here.
• Transaction type: Award/Grant (code A) — not a market purchase or sale.

Context
RSUs are compensation awards that convert to actual shares only as they vest; they do not represent an immediate open‑market purchase or sale. Such grants are routine executive compensation and should be viewed as part of pay/retention programs rather than a direct buy/sell signal.